Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-07-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0403249101PMID 15249654PMCID PMC489994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype.

  2004cited by this paper
• Progression of Early Carotid Atherosclerosis Is Only Temporarily Reduced After Antibiotic Treatment of Chlamydia pneumoniae Seropositivity

  2004cited by this paper
• Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

  2004cited by this paper
• Genetically Resistant Mice Lacking MyD88-Adapter Protein Display a High Susceptibility to Leishmania major Infection Associated with a Polarized Th2 Response1

  2003cited by this paper
• Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

  2003cited by this paper
• The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.

  2003cited by this paper
• Toll-like receptors in cardiovascular diseases.

  2003cited by this paper
• Chronic infection and coronary artery disease.

  2003cited by this paper
• Mechanisms of plaque vulnerability and rupture.

  2003cited by this paper
• Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences

  2003cited by this paper
• Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

  2003cited by this paper
• Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice.

  2003cited by this paper
• Toll-like receptor 4 and atherogenesis

  2003cited by this paper
• Cyclooxygenase Isoforms and Platelet Vessel Wall Interactions in the Apolipoprotein E Knockout Mouse Model of Atherosclerosis

  2003cited by this paper
• Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells*

  2003cited by this paper
• Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events

  2003cited by this paper
• Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

  2003cited by this paper
• Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8

  2003cited by this paper
• A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

  2003cited by this paper
• Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events

  2003cited by this paper
• Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.

  2003cited by this paper
• Chronic infection and coronary artery disease.

  2003cited by this paper
• Antibiotic Therapy After Acute Myocardial Infarction: A Prospective Randomized Study

  2003cited by this paper
• No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice

  2002cited by this paper
• Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice

  2002cited by this paper
• Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.

  2002cited by this paper
• Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation

  2002cited by this paper
• Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Vaccination against atherosclerosis: science or fiction?

  2002cited by this paper
• Reduced Progression of Early Carotid Atherosclerosis After Antibiotic Treatment and Chlamydia pneumoniae Seropositivity

  2002cited by this paper
• Innate and acquired immunity in atherogenesis

  2002cited by this paper
• Toll-like receptor 4 polymorphisms and atherogenesis.

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1

  2001cited by this paper
• Atherosclerosis The Road Ahead

  2001cited by this paper
• Cyclooxygenase-2 Blockade Does Not Impair Endothelial Vasodilator Function in Healthy Volunteers: Randomized Evaluation of Rofecoxib Versus Naproxen on Endothelium-Dependent Vasodilatation

  2001cited by this paper
• Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

  2001cited by this paper
• NF-κB: pivotal mediator or innocent bystander in atherogenesis?

  2001cited by this paper
• Toll-like receptors control activation of adaptive immune responses

  2001cited by this paper
• NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

  2001cited by this paper
• Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

  2001cited by this paper
• Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible Cyclooxygenase*

  2000cited by this paper
• Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism.

  2000cited by this paper
• Infectious Agents Are Not Necessary for Murine Atherogenesis

  2000cited by this paper
• TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

  2000cited by this paper
• Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

  1999cited by this paper
• Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)

  1999cited by this paper
• Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.

  1999cited by this paper
• The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice.

  1999cited by this paper
• The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations.

  1998cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Mouse Models of Atherosclerosis

  1996cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper

• Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy.

  2026cites this paper
• Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy.

  2026cites this paper
• MyD88-dependent signaling promotes smooth muscle cell phenotypic modulation and fibrous cap formation in murine atherosclerosis

  2025cites this paper
• Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets

  2025cites this paper
• Deciphering the tripartite interaction of urbanized environment, gut microbiome and cardio-metabolic disease.

  2025cites this paper
• Interleukin‐1 Signaling on Vascular Smooth Muscle Cells Accelerates Atherosclerosis in a Murine Model of Kawasaki Disease

  2025cites this paper
• Deciphering the Role of CD36 in Gestational Diabetes Mellitus: Linking Fatty Acid Metabolism and Inflammation in Disease Pathogenesis

  2025cites this paper
• Neutrophil elastase binds at the central domain of extracellular Toll-like receptor 4: AI prediction, docking, and validation in disease model

  2025cites this paper
• Enhanced lymphocyte infiltration in the liver of LDL receptor and Myeloid Differentiation 1 double knockout mice on high fat diet

  2025cites this paper
• Inflammation-induced endothelial cell activation and angiogenic sprouting are downmodulated by ubiquitin-specific peptidase 20

  2025cites this paper
• Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives

  2025cites this paper
• Environmental modulators of vascular physiology and inflammation

  2025cites this paper
• MyD88-dependent signalling promotes the recruitment of fibrous cap smooth muscle cells in murine atherosclerosis.

  2025cites this paper
• The alarmin tandem: unraveling the complex effect of S100A8/A9 – from atherosclerosis to cardiac arrhythmias

  2025cites this paper
• UCP1 prevents the formation of thoracic aortic aneurysms and dissection by inhibiting the TLR4/NLRP3/IL-1β signaling pathway and VSMC phenotype switching in mice.

  2025cites this paper
• NiOSP/dP nanocomposite attenuates hyperglycemia, oxidative stress, and inflammation in gestational diabetic rats through modulation of the TLR4/MyD88/NF-κB signaling pathway

  2025cites this paper
• A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia

  2025cites this paper
• Inflammatory Macrophage-Targeted Atherosclerosis Treatment by miRNA-Delivered, MRI-Visible, and Anti-Inflammatory Nanomedicine.

  2025cites this paper
• Treatment of T2DM-related inflammation and vascular injury by regulating cellular crosstalk in the islet microenvironment

  2025cites this paper
• Interplay Between KLF4, STAT, IRF, and NF-κB in VSMC and Macrophage Plasticity During Vascular Inflammation and Atherosclerosis

  2025cites this paper
• Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis.

  2024cites this paper
• Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being

  2024cites this paper
• Unveiling the therapeutic potential of miR‐146a: Targeting innate inflammation in atherosclerosis

  2024cites this paper
• Myocardial Expression of Pluripotency, Longevity, and Proinflammatory Genes in the Context of Hypercholesterolemia and Statin Treatment

  2024cites this paper
• Role of diet in development of non-communicable diseases: focus on gut microbiome.

  2024cites this paper
• The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease

  2024cites this paper
• Targeting the ACOD1-itaconate axis stabilizes atherosclerotic plaques

  2024cites this paper
• Innate immune sensing of cell death in disease and therapeutics

  2024cites this paper
• Immunological perspectives on atherosclerotic plaque formation and progression

  2024cites this paper
• Trem2/Tyrobp Signaling Protects Against Aortic Dissection and Rupture by Inhibiting Macrophage Activation in Mice

  2024cites this paper
• Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

  2024cites this paper
• Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway

  2024cites this paper
• The effect and mechanism of inulin on atherosclerosis is mediated by the characteristic intestinal flora and metabolites

  2024cites this paper
• Including microbiome information in a multi-trait genomic evaluation: a case study on longitudinal growth performance in beef cattle

  2024cites this paper
• The role of immune system in atherosclerosis: Molecular mechanisms, controversies, and future possibilities.

  2024cites this paper
• Increased Oxidative Stress and Decreased Sirtuin-3 and FOXO3 Expression Following Carotid Artery Intimal Injury in Hyperlipidemic Yucatan Microswine

  2024cites this paper
• Unravelling monocyte functions: from the guardians of health to the regulators of disease

  2024cites this paper
• Periodontal bacteria influence systemic diseases through the gut microbiota

  2024cites this paper
• Role and therapeutic potential of gelsolin in atherosclerosis.

  2023cites this paper
• Innate Immunity System in Patients With Cardiovascular and Kidney Disease

  2023cites this paper
• Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota

  2023cites this paper
• Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics.

  2023cites this paper
• The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV

  2023cites this paper
• Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2

  2023cites this paper
• Global research trends in atherosclerosis-related NF-κB: a bibliometric analysis from 2000 to 2021 and suggestions for future research

  2023cites this paper
• NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.

  2023cites this paper
• Activation of estrogen receptor α inhibits TLR4 signaling in macrophages and alleviates the instability of atherosclerotic plaques in the postmenopausal stage.

  2023cites this paper
• Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation

  2023cites this paper
• Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2

  2023cites this paper
• Amelioration of Atherosclerosis by lycopene is linked to the modulation of gut microbiota dysbiosis and related gut-heart axis activation in high-fat diet-fed ApoE−/− mice

  2023cites this paper
• Decreased toll-like receptor 4 and CD11b/CD18 expression on peripheral monocytes of hypertensive patients correlates with a lesser extent of endothelial damage: a preliminary study

  2023cites this paper
• Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming

  2023cites this paper
• MYD88 and Proinflammatory Chemokines in Aortic Atheromatosis: Exploring Novel Statin Effects

  2023cites this paper
• Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway.

  2023cites this paper
• Phosphorylation of USP20 on Ser334 by IRAK1 promotes IL-1β-evoked signaling in vascular smooth muscle cells and vascular inflammation

  2023cites this paper
• The Impacts of Animal-Based Diets in Cardiovascular Disease Development: A Cellular and Physiological Overview

  2023cites this paper
• The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis

  2023cites this paper
• Lipopolysaccharides and Cellular Senescence: Involvement in Atherosclerosis

  2022cites this paper
• Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro

  2022cites this paper
• Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics

  2022cites this paper
• AMPK integrates metabolite and kinase-based immunometabolic control in macrophages

  2022cites this paper
• Sulfated galactofucan from Sargassum thunbergii Attenuates atherosclerosis by suppressing in�ammation via TLR4/MyD88/NF-κB Signaling Pathway

  2022cites this paper
• Targeting Immune Senescence in Atherosclerosis

  2022cites this paper
• Cellular loci involved in the development of brain arteriovenous malformations

  2022cites this paper
• The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases

  2022cites this paper
• The Problem of Wound Healing in Diabetes—From Molecular Pathways to the Design of an Animal Model

  2022cites this paper
• Impact of myeloid differentiation protein 1 on cardiovascular disease.

  2022cites this paper
• Lipopolysaccharide Acting Via Toll Like Receptor 4 Transactivates The TGF-β Receptor in Vascular Smooth Muscle cells

  2022cites this paper
• Sulfated Galactofucan from Sargassum Thunbergii Attenuates Atherosclerosis by Suppressing Inflammation Via the TLR4/MyD88/NF-κB Signaling Pathway

  2022cites this paper
• The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites

  2022cites this paper
• Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4

  2022cites this paper
• Qinghao-Biejia Herb Pair Alleviates Pristane-Induced Lupus-Like Disease and Associated Renal and Aortic Lesions in ApoE−/− Mice

  2022cites this paper
• Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease

  2022cites this paper
• The truncated MyD88s negatively regulates TLR2 signal on expression of IL17-1 in oyster Crassostrea gigas.

  2022cites this paper
• The gut microbiota-artery axis: A bridge between dietary lipids and atherosclerosis?

  2022cites this paper
• Tetramethylpyrazine Alleviates Endothelial Glycocalyx Degradation and Promotes Glycocalyx Restoration via TLR4/NF-κB/HPSE1 Signaling Pathway During Inflammation

  2022cites this paper
• Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

  2022cites this paper
• Endothelial Cells: Potential Novel Regulators of Renal Inflammation.

  2022cites this paper
• Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis

  2022cites this paper
• Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages.

  2022cites this paper
• Endothelial Intracellular ANG (Angiogenin) Protects Against Atherosclerosis by Decreasing Endoplasmic Reticulum Stress

  2022cites this paper
• Coronary plaque vulnerability in statin-treated patients with elevated LDL-C and hs-CRP: optical coherence tomography study

  2022cites this paper
• Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis

  2022cites this paper
• C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosis

  2022cites this paper
• Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

  2022cites this paper
• Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling

  2022cites this paper
• Intertwining roles of circadian and metabolic regulation of the innate immune response

  2022cites this paper
• Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes

  2022cites this paper
• Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells

  2022cites this paper
• PET/MR imaging of inflammation in atherosclerosis

  2022cites this paper
• Frontiers of Calprotectin in Cardiovascular Field

  2022cites this paper
• Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages

  2021cites this paper
• The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients

  2021cites this paper
• Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

  2021cites this paper
• Functional Role of B Cells in Atherosclerosis

  2021cites this paper
• Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity

  2021cites this paper
• Berry-Derived Polyphenols in Cardiovascular Pathologies: Mechanisms of Disease and the Role of Diet and Sex

  2021cites this paper
• High Neutrophils/ lymphocyte ratio and MPO levels associated with low expression of miRNA-146a and apolipoprotein E in Type2 diabetic patients with atherosclerosis

  2021cites this paper
• Oat fiber attenuates circulating oxysterols levels and hepatic inflammation via targeting TLR4 signal pathway in LDL receptor knockout mice

  2021cites this paper
• Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway

  2021cites this paper